RSS
13 Nov 2026

Leqembi® Pen subcutaneous treatment launched in Japan

Author: admintech | Filed under: Press Release

STOCKHOLM, Nov. 13, 2026 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the treatment of early Alzheimer’s disease. Japan is the second country,…

This entry was posted on Friday, November 13th, 2026 at 2:17 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«